These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 6372684)
1. In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B. Hopfer RL; Mills K; Mehta R; Lopez-Berestein G; Fainstein V; Juliano RL Antimicrob Agents Chemother; 1984 Mar; 25(3):387-9. PubMed ID: 6372684 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. Anaissie E; Paetznick V; Proffitt R; Adler-Moore J; Bodey GP Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):665-8. PubMed ID: 1748123 [TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves. Ralph ED; Khazindar AM; Barber KR; Grant CW Antimicrob Agents Chemother; 1991 Jan; 35(1):188-91. PubMed ID: 2014976 [TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME). Cybulska B; Kupczyk K; Szlinder-Richert J; Borowski E Acta Biochim Pol; 2002; 49(1):67-75. PubMed ID: 12136958 [TBL] [Abstract][Full Text] [Related]
5. [Circular dichroism study of amphotericin B interaction with the sterols of Candida albicans strains sensitive and resistant to polyene antibiotics]. Belousova II; Virina AM; Petrov LN; Tereshin IM Antibiotiki; 1982 Feb; 27(2):95-8. PubMed ID: 7039498 [TBL] [Abstract][Full Text] [Related]
7. Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans. Sud IJ; Feingold DS Antimicrob Agents Chemother; 1983 Jan; 23(1):185-7. PubMed ID: 6299182 [TBL] [Abstract][Full Text] [Related]
8. [Effect of a subinhibitory dose of amphotericin B on cellular fatty acid and sterol composition of Candida albicans]. Mpona-Minga M; Hakkou A; Coulon J; Bonaly R Ann Inst Pasteur Microbiol; 1988; 139(5):547-55. PubMed ID: 3075500 [TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B. Meunier F; Lambert C; Van der Auwera P J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118 [TBL] [Abstract][Full Text] [Related]
10. The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles. Walker L; Sood P; Lenardon MD; Milne G; Olson J; Jensen G; Wolf J; Casadevall A; Adler-Moore J; Gow NAR mBio; 2018 Feb; 9(1):. PubMed ID: 29437927 [TBL] [Abstract][Full Text] [Related]
11. In-vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes. Pallister CJ; Johnson EM; Warnock DW; Elliot PJ; Reeves DF J Antimicrob Chemother; 1992 Sep; 30(3):313-20. PubMed ID: 1452496 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model. Lignell A; Löwdin E; Cars O; Sjölin J J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237 [TBL] [Abstract][Full Text] [Related]
13. In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: effect of concentration and exposure time. Ernst EJ; Klepser ME; Pfaller MA Diagn Microbiol Infect Dis; 1998 Nov; 32(3):205-10. PubMed ID: 9884837 [TBL] [Abstract][Full Text] [Related]
14. Unique aggregation of conjugated amphotericin B and its interaction with lipid membranes. Kagan S; Ickowicz DE; Domb AJ; Dagan A; Polacheck I Med Mycol; 2017 Jun; 55(4):414-421. PubMed ID: 28339539 [TBL] [Abstract][Full Text] [Related]
15. Role of macrophages in the candidacidal activity of liposomal amphotericin B. Mehta RT; Poddar S; Kalidas M; Gomez-Flores R; Dulski K J Infect Dis; 1997 Jan; 175(1):214-7. PubMed ID: 8985224 [TBL] [Abstract][Full Text] [Related]
16. Antagonism by sterols of the action of amphotericin and filipin on the release of potassium ions from Candida albicans and Mycoplasma mycoides subsp. capri. Archer DB; Gale EF J Gen Microbiol; 1975 Sep; 90(1):187-90. PubMed ID: 1100776 [No Abstract] [Full Text] [Related]
17. Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans. van Etten EW; Chander HR; Snijders SV; Bakker-Woudenberg IA J Antimicrob Chemother; 1995 Dec; 36(6):961-74. PubMed ID: 8821595 [TBL] [Abstract][Full Text] [Related]
18. Synergistic antifungal activity and reduced toxicity of liposomal amphotericin B combined with gramicidin S or NF. Hopfer RL; Mehta R; Lopez-Berestein G Antimicrob Agents Chemother; 1987 Dec; 31(12):1978-81. PubMed ID: 2449867 [TBL] [Abstract][Full Text] [Related]
19. Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. Lopez-Berestein G; Mehta R; Hopfer R; Mehta K; Hersh EM; Juliano R Cancer Drug Deliv; 1983; 1(1):37-42. PubMed ID: 6544116 [TBL] [Abstract][Full Text] [Related]
20. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans. Klepser ME; Wolfe EJ; Jones RN; Nightingale CH; Pfaller MA Antimicrob Agents Chemother; 1997 Jun; 41(6):1392-5. PubMed ID: 9174207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]